Editas Medicine, Inc.
EDIT
$2.76
-$0.07-2.47%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 30.03% | -67.61% | 26.95% | 8.08% | -9.13% |
| Total Depreciation and Amortization | -4.33% | 38.81% | -13.63% | 12.61% | 0.78% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -33.66% | 63.65% | 48.02% | 33.15% | -53.74% |
| Change in Net Operating Assets | -126.23% | 245.59% | -378.84% | -32.31% | 33.54% |
| Cash from Operations | -5.05% | 5.84% | 3.47% | 7.84% | -14.42% |
| Capital Expenditure | 100.00% | 78.89% | 81.51% | 16.40% | -86.75% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -24.78% | 79.38% | -63.75% | 56.72% | 2,029.30% |
| Cash from Investing | -24.36% | 82.14% | -63.14% | 61.64% | 1,194.92% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 416.52% | 433.46% | -- | -100.00% | 67.71% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -105.20% | -- | -- | -- |
| Cash from Financing | 615.80% | -102.59% | -- | -100.00% | 67.71% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -102.10% | -79.97% | 13.76% | 755.89% | 91.21% |